RxDoctor Payments Data

Jodi Strong

Nurse Practitioner · Stevens Point, WINPI 1013234889

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $188,168 of the $246,436 with a category attached, or 76.4%. 10 manufacturers reported payments, led by Novo Nordisk at 43.7% of the total. Reporting peaked in 2022 at $97,255 and has fallen 73.6% since, to $25,648 in 2025. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$246,436in general payments, 2019–2025

Across 370 payments — averaging $666.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$108K
  • Abbott$45K
  • Sanofi-aventis U.S. LLC$34K
  • Boehringer Ingelheim$31K
  • Lilly USA, LLC$27K
  • Sanofi$1K
  • plus $1K from 4 others

What the payments were for

  • Consulting fees$15,6926%
  • Speaking & faculty fees$188,16876%
  • Travel & lodging$35,43114%
  • Food & beverage$7,1453%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk168$107,805
Abbott85$44,667
Sanofi-aventis U.S. LLC41$34,325
Boehringer Ingelheim44$30,673
Lilly USA, LLC24$26,581
Sanofi1$1,344
AstraZeneca1$600
Dexcom, Inc.2$192
Medtronic2$162
BETA Bionics, Inc.2$88

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$246,436 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide729$1,056,124
MounjaroTirzepatide442$583,853
JardianceEmpagliflozin467$539,369
TrulicityDulaglutide326$463,678
Tresiba Flextouch U-200Insulin Degludec236$326,758
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog89$133,250
Humulin R U-500 KwikpenInsulin Regular, Human21$128,548
Synjardy XrEmpagliflozin/Metformin Hcl77$109,589
RybelsusSemaglutide54$100,750
FarxigaDapagliflozin Propanediol85$98,671
Xultophy 100-3.6Insulin Degludec/Liraglutide38$77,092
JanuviaSitagliptin Phosphate70$72,953
Soliqua 100-33Insulin Glargine/Lixisenatide43$72,733
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog91$59,339
Fiasp FlextouchInsulin Aspart (Niacinamide)44$52,771

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Xultophy 100-3.6, Novolog$107,805$1,242,661848 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro$26,581$1,068,626812 claims
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta$30,673$666,249557 claims
AstraZenecaFarxiga$600$98,67185 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$34,325$72,73343 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Stevens Point

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →